Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. (Q39313078)

10 September 2017

title

Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. (English)

1 reference

10 September 2017

1 reference

Yong Yi

1

1 reference

10 September 2017

Han Wu

2

1 reference

10 September 2017

Qiang Gao

3

1 reference

10 September 2017

Hong-Wei He

4

1 reference

10 September 2017

Yi-Wei Li

5

1 reference

10 September 2017

Xiao-Yan Cai

6

1 reference

10 September 2017

Jia-Xing Wang

7

1 reference

10 September 2017

Jian Zhou

8

1 reference

10 September 2017

Yun-Feng Cheng

9

1 reference

10 September 2017

Jian-Jun Jin

10

1 reference

10 September 2017

Jia Fan

11

1 reference

10 September 2017

Shuang-Jian Qiu

12

1 reference

10 September 2017

publication date

18 July 2012

1 reference

Annals of Surgical Oncology

10 September 2017

published in

1 reference

10 September 2017

volume

20

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

267-276

1 reference

Epidemiology and prevention of hepatocellular carcinoma

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Mechanisms of type-I- and type-II-interferon-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Interferon regulatory factor-1 and -2 expression in human melanoma specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Quantitation of interferon regulatory factor transcripts in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Activation of stat3 in human melanoma promotes brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

Interferon Regulatory Factor 1 (IRF-1) and IRF-2 Expression in Breast Cancer Tissue Microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2487-Z

10.1245/S10434-012-2487-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

10 September 2017

1032357837

0 references

Fatcat ID

release_f76pmwzx7jbdlg5w32lb7pmyg4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f76pmwzx7jbdlg5w32lb7pmyg4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference